Candela Medical, Inc. (CDLA)
| Market Cap | 1.66B |
| Revenue (ttm) | 390.18M |
| Net Income (ttm) | 6.73M |
| Shares Out | 97.70M |
| EPS (ttm) | 0.07 |
| PE Ratio | 246.78 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Range | n/a |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About CDLA
Candela Medical is a leading provider of advanced medical device solutions for a broad range of aesthetic applications. Our brands and products have been recognized for their innovation and as leaders in the high growth medical aesthetics space for almost 40 years. We provide energy-based solutions for primarily elective, cash pay procedures that utilize our leading technologies in laser, pulsed light, radiofrequency and microneedling. Our brand promise of “Science. Results. Trust.” guides our commitment to patients who can expect efficacio...
Financial Performance
In 2020, CDLA's revenue was $321.65 million, a decrease of -17.48% compared to the previous year's $389.77 million. Losses were -$43.89 million, 25.8% more than in 2019.
Financial StatementsNews
Candela Medical IPO Registration Document (S-1)
Candela Medical, Inc. has filed to go public with an IPO on the NASDAQ.